Definition of Frequently Relapsing Nephrotic Syndrome
Frequently relapsing nephrotic syndrome (FRNS) is defined as 2 or more relapses within the first 6 months of diagnosis OR 4 or more relapses within any 12-month period. 1
Detailed Diagnostic Criteria
Temporal Patterns for FRNS Classification
In pediatric patients:
- 2 or more relapses within 6 months of initial diagnosis, OR 1
- 4 or more relapses within any 12-month period 1
In adult patients:
- 2 or more relapses within 6 months, OR 1
- The same temporal criteria apply as in pediatric populations 1
What Constitutes a "Relapse"
Pediatric definition:
- Urine protein 3+ on dipstick (Albu-stix) OR proteinuria >40 mg/m²/h occurring on 3 consecutive days within 1 week 1
- Must occur after complete remission has been maintained for >1 month 1
Adult definition:
- Proteinuria >3.5 g/day occurring after complete remission has been obtained for >1 month 1
Clinical Significance and Implications
Disease Burden
- Children with FRNS (≥4 relapses in 12 months) will have significant cumulative exposure to high-dose corticosteroids throughout their disease course 1
- The majority of these children will develop at least 1 severe steroid side effect, including growth failure, obesity, hypertension, diabetes, osteoporosis, behavioral concerns, or cataracts 1
Treatment Threshold
- Glucocorticoid-sparing agents should be offered to children with FRNS to reduce steroid toxicity 1
- Options include cyclophosphamide, calcineurin inhibitors (CNIs), levamisole, mycophenolate, or rituximab 1
Important Distinctions from Related Entities
FRNS vs. Steroid-Dependent Nephrotic Syndrome (SDNS)
SDNS is defined as:
Key difference: SDNS relapses occur specifically in relation to steroid dose reduction or discontinuation, while FRNS is defined purely by relapse frequency regardless of steroid timing 1
FRNS vs. Steroid-Resistant Nephrotic Syndrome (SRNS)
SRNS is defined as:
- No remission achieved after 8 weeks of corticosteroid treatment in children 1
- Persistence of proteinuria despite prednisone 1 mg/kg/day for >4 months in adults 1
Common Pitfalls to Avoid
- Do not confuse early relapse timing with FRNS diagnosis: A single relapse within 30 days of steroid discontinuation predicts high risk of SDNS/FRNS development (96% incidence within 6 months), but does not itself define FRNS 2
- Count relapses accurately: The definition requires counting actual relapse episodes, not just proteinuria measurements 1
- Distinguish from late-onset steroid resistance: If remission is not achieved by 6 weeks of treatment, consider SRNS rather than FRNS 1